Ono Pharmaceutical Co., Ltd. (TYO: 4528)

Ono Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	134,248	166,141	96,135	69,112	61,045	69,005
Short-Term Investments	16,670	-	20	60	2,978	614
Cash & Short-Term Investments	150,918	166,141	96,155	69,172	64,023	69,619
Cash Growth	149.65%	72.78%	39.01%	8.04%	-8.04%	14.75%
Receivables	150,354	136,066	114,396	99,788	84,269	76,834
Inventory	53,282	48,629	44,814	41,817	39,151	32,906
Prepaid Expenses	-	14,699	10,465	10,952	10,003	8,094
Other Current Assets	32,734	48,061	79,271	59,537	50,196	37,769
Total Current Assets	387,288	413,596	345,101	281,266	247,642	225,222
Property, Plant & Equipment	108,673	104,752	108,420	112,131	113,866	114,628
Long-Term Investments	121,417	297,170	324,178	255,997	281,393	232,344
Other Intangible Assets	56,482	57,288	69,134	64,734	70,322	66,436
Long-Term Deferred Tax Assets	42,262	40,863	35,604	25,074	33,619	34,817
Other Long-Term Assets	11,694	-1	-	1	-	-3
Total Assets	1,083,697	913,668	882,437	739,203	746,842	673,444
Accounts Payable	60,684	60,691	66,794	49,689	39,163	34,439
Accrued Expenses	-	13,493	11,726	10,824	10,393	10,425
Short-Term Debt	150,000	-	-	-	-	-
Current Portion of Leases	2,889	2,310	2,490	2,301	2,023	2,188
Current Income Taxes Payable	9,496	24,518	40,896	2,284	20,804	22,975
Other Current Liabilities	29,676	2,612	1,023	828	21,350	21,302
Total Current Liabilities	252,745	103,624	122,929	65,926	93,733	91,329
Long-Term Leases	9,718	6,552	6,678	6,501	7,030	6,173
Long-Term Deferred Tax Liabilities	1,022	1,013	983	1,009	1,052	1,059
Other Long-Term Liabilities	548	580	684	771	814	813
Total Liabilities	267,284	115,063	134,624	77,529	105,685	105,422
Common Stock	17,358	17,358	17,358	17,358	17,358	17,358
Additional Paid-In Capital	-	17,458	17,080	17,241	17,231	17,229
Retained Earnings	775,684	768,183	709,890	644,754	583,363	524,605
Treasury Stock	-63,234	-63,233	-54,161	-74,683	-44,705	-44,737
Comprensive Income & Other	80,923	53,195	51,702	51,236	62,300	48,029
Total Common Equity	810,731	792,961	741,869	655,906	635,547	562,484
Minority Interest	5,682	5,644	5,944	5,768	5,610	5,538
Shareholders' Equity	816,413	798,605	747,813	661,674	641,157	568,022
Total Liabilities & Equity	1,083,697	913,668	882,437	739,203	746,842	673,444
Total Debt	162,607	8,862	9,168	8,802	9,053	8,361
Net Cash (Debt)	-11,689	157,279	86,987	60,370	54,970	61,258
Net Cash Growth	-	80.81%	44.09%	9.82%	-10.26%	4.77%
Net Cash Per Share	-24.89	327.64	178.12	121.58	110.12	121.53
Filing Date Shares Outstanding	469.64	469.65	488.33	488.31	499.21	499.12
Total Common Shares Outstanding	469.64	469.65	488.33	488.24	499.14	499.12
Working Capital	134,543	309,972	222,172	215,340	153,909	133,893
Book Value Per Share	1726.26	1688.42	1519.18	1343.40	1273.28	1126.95
Tangible Book Value	398,368	735,673	672,735	591,172	565,225	496,048
Tangible Book Value Per Share	848.23	1566.44	1377.61	1210.81	1132.39	993.85

Source: S&P Capital IQ. Standard template. Financial Sources.